BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guzman SJ, Gerevich Z. P2Y Receptors in Synaptic Transmission and Plasticity: Therapeutic Potential in Cognitive Dysfunction. Neural Plast 2016;2016:1207393. [PMID: 27069691 DOI: 10.1155/2016/1207393] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 6.2] [Reference Citation Analysis]
Number Citing Articles
1 Al Omairi NE, Radwan OK, Alzahrani YA, Kassab RB. Neuroprotective efficiency of Mangifera indica leaves extract on cadmium-induced cortical damage in rats. Metab Brain Dis 2018;33:1121-30. [PMID: 29557530 DOI: 10.1007/s11011-018-0222-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
2 Menéndez Méndez A, Smith J, Engel T. Neonatal Seizures and Purinergic Signalling. Int J Mol Sci 2020;21:E7832. [PMID: 33105750 DOI: 10.3390/ijms21217832] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Alves M, Smith J, Engel T. Differential Expression of the Metabotropic P2Y Receptor Family in the Cortex Following Status Epilepticus and Neuroprotection via P2Y1 Antagonism in Mice. Front Pharmacol 2019;10:1558. [PMID: 32009961 DOI: 10.3389/fphar.2019.01558] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
4 Silva CA, Yalnizyan-Carson A, Fernández Busch MV, van Zwieten M, Verhage M, Lohmann C. Activity-dependent regulation of mitochondrial motility in developing cortical dendrites. Elife 2021;10:e62091. [PMID: 34491202 DOI: 10.7554/eLife.62091] [Reference Citation Analysis]
5 Bukhari SA, Saul MC, Seward CH, Zhang H, Bensky M, James N, Zhao SD, Chandrasekaran S, Stubbs L, Bell AM. Temporal dynamics of neurogenomic plasticity in response to social interactions in male threespined sticklebacks. PLoS Genet 2017;13:e1006840. [PMID: 28704398 DOI: 10.1371/journal.pgen.1006840] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 8.6] [Reference Citation Analysis]
6 Eszlari N, Bruncsics B, Millinghoffer A, Hullam G, Petschner P, Gonda X, Breen G, Antal P, Bagdy G, Deakin JFW, Juhasz G. Biology of Perseverative Negative Thinking: The Role of Timing and Folate Intake. Nutrients 2021;13:4396. [PMID: 34959947 DOI: 10.3390/nu13124396] [Reference Citation Analysis]
7 Le HTT, Rimpilainen T, Konda Mani S, Murugesan A, Yli-Harja O, Candeias NR, Kandhavelu M. Synthesis and preclinical validation of novel P2Y1 receptor ligands as a potent anti-prostate cancer agent. Sci Rep 2019;9:18938. [PMID: 31831761 DOI: 10.1038/s41598-019-55194-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
8 Aslam N, Alvi F. TRPC3 Channel Activity and Viability of Purkinje Neurons can be Regulated by a Local Signalosome. Front Mol Biosci 2022;9:818682. [DOI: 10.3389/fmolb.2022.818682] [Reference Citation Analysis]
9 Alves VS, Leite-Aguiar R, Silva JPD, Coutinho-Silva R, Savio LEB. Purinergic signaling in infectious diseases of the central nervous system. Brain Behav Immun 2020;89:480-90. [PMID: 32717399 DOI: 10.1016/j.bbi.2020.07.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
10 Yeung AK, Patil CS, Jackson MF. Pannexin‐1 in the CNS: Emerging concepts in health and disease. J Neurochem 2020;154:468-85. [DOI: 10.1111/jnc.15004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
11 Barańska J, Czajkowski R, Pomorski P. P2Y1 Receptors - Properties and Functional Activities. Adv Exp Med Biol 2017;1051:71-89. [PMID: 28639247 DOI: 10.1007/5584_2017_57] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
12 Zarrinmayeh H, Territo PR. Purinergic Receptors of the Central Nervous System: Biology, PET Ligands, and Their Applications. Mol Imaging 2020;19:1536012120927609. [PMID: 32539522 DOI: 10.1177/1536012120927609] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
13 Matyash M, Zabiegalov O, Wendt S, Matyash V, Kettenmann H. The adenosine generating enzymes CD39/CD73 control microglial processes ramification in the mouse brain. PLoS One 2017;12:e0175012. [PMID: 28376099 DOI: 10.1371/journal.pone.0175012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 6.6] [Reference Citation Analysis]
14 Huang J, You X, Liu W, Song C, Lin X, Zhang X, Tao J, Chen L. Electroacupuncture ameliorating post-stroke cognitive impairments via inhibition of peri-infarct astroglial and microglial/macrophage P2 purinoceptors-mediated neuroinflammation and hyperplasia. BMC Complement Altern Med 2017;17:480. [PMID: 29017492 DOI: 10.1186/s12906-017-1974-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
15 Sanchez-Arias JC, van der Slagt E, Vecchiarelli HA, Candlish RC, York N, Young PA, Shevtsova O, Juma A, Tremblay MÈ, Swayne LA. Purinergic signaling in nervous system health and disease: Focus on pannexin 1. Pharmacol Ther 2021;225:107840. [PMID: 33753132 DOI: 10.1016/j.pharmthera.2021.107840] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Freyberg Z, Logan RW. The Intertwined Roles of Circadian Rhythms and Neuronal Metabolism Fueling Drug Reward and Addiction. Curr Opin Physiol 2018;5:80-9. [PMID: 30631826 DOI: 10.1016/j.cophys.2018.08.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
17 Kita M, Ano Y, Inoue A, Aoki J. Identification of P2Y receptors involved in oleamide-suppressing inflammatory responses in murine microglia and human dendritic cells. Sci Rep 2019;9:3135. [PMID: 30816271 DOI: 10.1038/s41598-019-40008-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
18 Agostinho P, Madeira D, Dias L, Simões AP, Cunha RA, Canas PM. Purinergic signaling orchestrating neuron-glia communication. Pharmacol Res 2020;162:105253. [PMID: 33080321 DOI: 10.1016/j.phrs.2020.105253] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
19 Jha SK, Jha NK, Kumar D, Sharma R, Shrivastava A, Ambasta RK, Kumar P. Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer's Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets? J Alzheimers Dis 2017;57:1017-39. [PMID: 27662312 DOI: 10.3233/JAD-160623] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
20 Gaidin SG, Turovskaya MV, Mal’tseva VN, Zinchenko VP, Blinova EV, Turovsky EA. A Complex Neuroprotective Effect of Alpha-2-Adrenergic Receptor Agonists in a Model of Cerebral Ischemia–Reoxygenation In Vitro. Biochem Moscow Suppl Ser A 2019;13:319-33. [DOI: 10.1134/s1990747819040068] [Cited by in Crossref: 10] [Article Influence: 5.0] [Reference Citation Analysis]
21 Guerra G, Lucariello A, Perna A, Botta L, De Luca A, Moccia F. The Role of Endothelial Ca2+ Signaling in Neurovascular Coupling: A View from the Lumen. Int J Mol Sci 2018;19:E938. [PMID: 29561829 DOI: 10.3390/ijms19040938] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 10.0] [Reference Citation Analysis]
22 He P, Zhou W, Liu M, Chen Y. Recent Advances of Small Molecular Regulators Targeting G Protein- Coupled Receptors Family for Oncology Immunotherapy. Curr Top Med Chem 2019;19:1464-83. [PMID: 31264549 DOI: 10.2174/1568026619666190628115644] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
23 Alves M, Gomez-Villafuertes R, Delanty N, Farrell MA, O'Brien DF, Miras-Portugal MT, Hernandez MD, Henshall DC, Engel T. Expression and function of the metabotropic purinergic P2Y receptor family in experimental seizure models and patients with drug-refractory epilepsy. Epilepsia 2017;58:1603-14. [PMID: 28733972 DOI: 10.1111/epi.13850] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
24 Guo X, Li Q, Pi S, Xia Y, Mao L. G protein-coupled purinergic P2Y receptor oligomerization: Pharmacological changes and dynamic regulation. Biochem Pharmacol 2021;192:114689. [PMID: 34274353 DOI: 10.1016/j.bcp.2021.114689] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Jacobson KA, IJzerman AP, Müller CE. Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets. Biochem Pharmacol 2021;187:114311. [PMID: 33130128 DOI: 10.1016/j.bcp.2020.114311] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
26 Moldovan RP, Wenzel B, Teodoro R, Neumann W, Dukic-Stefanovic S, Kraus W, Rong P, Deuther-Conrad W, Hey-Hawkins E, Krügel U, Brust P. Studies towards the development of a PET radiotracer for imaging of the P2Y1 receptors in the brain: synthesis, 18F-labeling and preliminary biological evaluation. Eur J Med Chem 2019;165:142-59. [PMID: 30665144 DOI: 10.1016/j.ejmech.2019.01.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
27 France G, Volianskis R, Ingram R, Bannister N, Rothärmel R, Irvine MW, Fang G, Burnell ES, Sapkota K, Costa BM, Chopra DA, Dravid SM, Michael-Titus AT, Monaghan DT, Georgiou J, Bortolotto ZA, Jane DE, Collingridge GL, Volianskis A. Differential regulation of STP, LTP and LTD by structurally diverse NMDA receptor subunit-specific positive allosteric modulators. Neuropharmacology 2022;202:108840. [PMID: 34678377 DOI: 10.1016/j.neuropharm.2021.108840] [Reference Citation Analysis]
28 Alves M, De Diego Garcia L, Conte G, Jimenez-Mateos EM, D'Orsi B, Sanz-Rodriguez A, Prehn JHM, Henshall DC, Engel T. Context-Specific Switch from Anti- to Pro-epileptogenic Function of the P2Y1 Receptor in Experimental Epilepsy. J Neurosci 2019;39:5377-92. [PMID: 31048325 DOI: 10.1523/JNEUROSCI.0089-19.2019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 5.7] [Reference Citation Analysis]
29 Beamer E, Kuchukulla M, Boison D, Engel T. ATP and adenosine-Two players in the control of seizures and epilepsy development. Prog Neurobiol 2021;204:102105. [PMID: 34144123 DOI: 10.1016/j.pneurobio.2021.102105] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Engel T, Smith J, Alves M. Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy. J Inflamm Res 2021;14:3367-92. [PMID: 34305404 DOI: 10.2147/JIR.S287740] [Reference Citation Analysis]
31 Rotermund N, Schulz K, Hirnet D, Lohr C. Purinergic Signaling in the Vertebrate Olfactory System. Front Cell Neurosci 2019;13:112. [PMID: 31057369 DOI: 10.3389/fncel.2019.00112] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
32 Aslam N, Alvi F. Simplified Model of PKCγ Signaling Dysregulation and Cytosol-to-Membrane Translocation Kinetics During Neurodegenerative Spinocerebellar Ataxia Type 14 (SCA14). Front Neurosci 2019;13:1397. [PMID: 32082104 DOI: 10.3389/fnins.2019.01397] [Reference Citation Analysis]
33 Baez-Jurado E, Rincón-Benavides MA, Hidalgo-Lanussa O, Guio-Vega G, Ashraf GM, Sahebkar A, Echeverria V, Garcia-Segura LM, Barreto GE. Molecular mechanisms involved in the protective actions of Selective Estrogen Receptor Modulators in brain cells. Front Neuroendocrinol 2019;52:44-64. [PMID: 30223003 DOI: 10.1016/j.yfrne.2018.09.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
34 Lommen J, Detken J, Harr K, von Gall C, Ali AAH. Analysis of Spatial and Temporal Distribution of Purinergic P2 Receptors in the Mouse Hippocampus. Int J Mol Sci 2021;22:8078. [PMID: 34360844 DOI: 10.3390/ijms22158078] [Reference Citation Analysis]
35 Rozmer K, Gao P, Araújo MGL, Khan MT, Liu J, Rong W, Tang Y, Franke H, Krügel U, Fernandes MJS, Illes P. Pilocarpine-Induced Status Epilepticus Increases the Sensitivity of P2X7 and P2Y1 Receptors to Nucleotides at Neural Progenitor Cells of the Juvenile Rodent Hippocampus. Cereb Cortex 2017;27:3568-85. [PMID: 27341850 DOI: 10.1093/cercor/bhw178] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
36 Le Duc D, Schulz A, Lede V, Schulze A, Thor D, Brüser A, Schöneberg T. P2Y Receptors in Immune Response and Inflammation. Adv Immunol 2017;136:85-121. [PMID: 28950952 DOI: 10.1016/bs.ai.2017.05.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
37 Alves M, Beamer E, Engel T. The Metabotropic Purinergic P2Y Receptor Family as Novel Drug Target in Epilepsy. Front Pharmacol 2018;9:193. [PMID: 29563872 DOI: 10.3389/fphar.2018.00193] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
38 Burnstock G. Purinergic Signalling: Therapeutic Developments. Front Pharmacol 2017;8:661. [PMID: 28993732 DOI: 10.3389/fphar.2017.00661] [Cited by in Crossref: 170] [Cited by in F6Publishing: 164] [Article Influence: 34.0] [Reference Citation Analysis]
39 Illes P, Burnstock G, Tang Y. Astroglia-Derived ATP Modulates CNS Neuronal Circuits. Trends Neurosci 2019;42:885-98. [PMID: 31704181 DOI: 10.1016/j.tins.2019.09.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]